Literature DB >> 20032258

First case of human infection due to Pseudomonas fulva, an environmental bacterium isolated from cerebrospinal fluid.

Marisa N Almuzara1, Miryam Vazquez, Naoto Tanaka, Marisa Turco, Maria S Ramirez, Eduardo L Lopez, Fernando Pasteran, Melina Rapoport, Adriana Procopio, Carlos A Vay.   

Abstract

We report the first case of human infection due to Pseudomonas fulva. P. fulva caused acute meningitis following the placement of a drainage system in a 2-year-old female. Additionally, the isolate displayed a VIM-2 carbapenemase in a class 1 integron context.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20032258      PMCID： PMC2815644          DOI： 10.1128/JCM.01849-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  23 in total

1.  First isolation of bla(VIM-2) in Latin America: report from the SENTRY Antimicrobial Surveillance Program.

Authors:  Rodrigo E Mendes; Mariana Castanheira; Patricia Garcia; Manuel Guzman; Mark A Toleman; Timothy R Walsh; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

2.  Novel variant (bla(VIM-11)) of the metallo-{beta}-lactamase bla(VIM) family in a GES-1 extended-spectrum-{beta}-lactamase-producing Pseudomonas aeruginosa clinical isolate in Argentina.

Authors:  Fernando Pasteran; Diego Faccone; Alejandro Petroni; Melina Rapoport; Marcelo Galas; Miryam Vázquez; Adriana Procopio
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

3.  Sensitive EDTA-based microbiological assays for detection of metallo-{beta}-lactamases in nonfermentative gram-negative bacteria.

Authors:  Patricia Marchiaro; María A Mussi; Viviana Ballerini; Fernando Pasteran; Alejandro M Viale; Alejandro J Vila; Adriana S Limansky
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

4.  16S ribosomal DNA amplification for phylogenetic study.

Authors:  W G Weisburg; S M Barns; D A Pelletier; D J Lane
Journal:  J Bacteriol       Date:  1991-01       Impact factor: 3.490

5.  Detection of beta-lactamase production by gram-negative bacteria.

Authors:  G Masuda; S Tomioka; M Hasegawa
Journal:  J Antibiot (Tokyo)       Date:  1976-06       Impact factor: 2.649

6.  Isolation and identification of an ice-nucleating bacterium from the gills of the intertidal bivalve mollusc Geukensia demissa.

Authors:  S H. Loomis; M Zinser
Journal:  J Exp Mar Bio Ecol       Date:  2001-07-01       Impact factor: 2.171

7.  Amino acid substitutions in a variant of IMP-1 metallo-beta-lactamase.

Authors:  S Iyobe; H Kusadokoro; J Ozaki; N Matsumura; S Minami; S Haruta; T Sawai; K O'Hara
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

8.  Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France.

Authors:  L Poirel; T Naas; D Nicolas; L Collet; S Bellais; J D Cavallo; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

9.  Multiple antibiotic-resistance mechanisms including a novel combination of extended-spectrum beta-lactamases in a Klebsiella pneumoniae clinical strain isolated in Argentina.

Authors:  Roberto Melano; Alejandra Corso; Alejandro Petroni; Daniela Centrón; Betina Orman; Adriana Pereyra; Noemí Moreno; Marcelo Galas
Journal:  J Antimicrob Chemother       Date:  2003-05-29       Impact factor: 5.790

10.  VIM-2-producing Pseudomonas putida, Buenos Aires.

Authors:  Marisa Almuzara; Marcela Radice; Natalia de Gárate; Alejandra Kossman; Arabela Cuirolo; Gisela Santella; Angela Famiglietti; Gabriel Gutkind; Varolos Vay
Journal:  Emerg Infect Dis       Date:  2007-04       Impact factor: 6.883
View more
  6 in total

1.  Polymicrobial ventriculitis involving Pseudomonas fulva.

Authors:  Paulina A Rebolledo; Catphuong Cathy L Vu; Renee Donahue Carlson; Colleen S Kraft; Evan J Anderson; Eileen M Burd
Journal:  J Clin Microbiol       Date:  2014-03-19       Impact factor: 5.948

2.  First report of an extensively drug-resistant VIM-2 metallo-β-lactamase-producing Brevundimonas diminuta clinical isolate.

Authors:  Marisa N Almuzara; Claudia M Barberis; Carlos H Rodríguez; Angela M R Famiglietti; Maria S Ramirez; Carlos A Vay
Journal:  J Clin Microbiol       Date:  2012-06-12       Impact factor: 5.948

3.  Identification of bacteria in blood culture broths using matrix-assisted laser desorption-ionization Sepsityper™ and time of flight mass spectrometry.

Authors:  Jen Kok; Lee C Thomas; Thomas Olma; Sharon C A Chen; Jonathan R Iredell
Journal:  PLoS One       Date:  2011-08-16       Impact factor: 3.240

4.  Brain microbial populations in HIV/AIDS: α-proteobacteria predominate independent of host immune status.

Authors:  William G Branton; Kristofor K Ellestad; Ferdinand Maingat; B Matt Wheatley; Erling Rud; René L Warren; Robert A Holt; Michael G Surette; Christopher Power
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

5.  Abattoirs as non-hospital source of extended spectrum beta lactamase producers: confirmed by the double disc synergy test and characterized by matrix-assisted laser desorption/ionization time of flight mass spectrometry.

Authors:  Moses Nkechukwu Ikegbunam; Linda Onyeka Anagu; Ifeanyi R Iroha; Chika Ebiye Ejikeugwu; Charles Okey Esimone
Journal:  PLoS One       Date:  2014-04-11       Impact factor: 3.240

6.  Posttraumatic Skin and Soft-Tissue Infection due to Pseudomonas fulva.

Authors:  Fernando Cobo; Gemma Jiménez; Javier Rodríguez-Granger; Antonio Sampedro
Journal:  Case Rep Infect Dis       Date:  2016-09-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.